Lifecycle Management
Comprehensive Lifecycle Management
NFJ Consulting understands that each stage of lifecycle management is crucial — from the initial concept to development to marketing and beyond. As such, our consulting firm designs custom, in-depth pharmaceutical lifecycle programs that help reveal hidden opportunities for brand growth and defense in today’s markets all over the world.
Early Action
By taking early action, we can identify crucial opportunities to extend a product’s life in the following ways:Â
- Discovering the potential for new indications and product combinations
- Improving a drug’s formulation for more convenient patient intake
- Investigating usage for pediatric and or elderly age groups
- Managing food and drug interactions
- Controlling potential toxic impurities
- Investigating IP rights across markets
- Spreading awareness and improving patient access by evaluating early social licensing rights and social partnering opportunities
Later Action
We can deliver other options by providing later action efforts to ensure the product fulfills its lifecycle predictions. These include:
- Running market intelligence to forecast generic development and entry across markets
- Giving advice for preparing legal, policy, and communication teams to handle potential infringement of rights issues and provide adequate training
- Mapping out competition and unanticipated toxic policy opposition, such as the preparation for potential compulsory licensingÂ
- Safeguarding against premature copy competition through lab testing preparation
- Allocating time and resources to forecast and mitigate sales erosion through scalable marketing and trade efforts
- Managing ongoing portfolio management programs to evaluate out-licensing and opportunities to prune portfolios
For a deeper dive into our expertise, ongoing projects, and commentary on timely issues, please visit the NFJ Consulting Blog.Â
